1. Home
  2. INDO vs TELA Comparison

INDO vs TELA Comparison

Compare INDO & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Indonesia Energy Corporation Limited

INDO

Indonesia Energy Corporation Limited

HOLD

Current Price

$2.80

Market Cap

47.2M

Sector

Energy

ML Signal

HOLD

TELA

TELA Bio Inc.

HOLD

Current Price

$0.87

Market Cap

41.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDO
TELA
Founded
2018
2012
Country
Indonesia
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.2M
41.0M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
INDO
TELA
Price
$2.80
$0.87
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.00
AVG Volume (30 Days)
257.4K
76.2K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.59
EPS
N/A
N/A
Revenue
N/A
$80,275,000.00
Revenue This Year
N/A
$10.23
Revenue Next Year
N/A
$14.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.84
52 Week Low
$2.44
$0.50
52 Week High
$8.50
$2.14

Technical Indicators

Market Signals
Indicator
INDO
TELA
Relative Strength Index (RSI) 46.45 58.44
Support Level $2.63 $0.78
Resistance Level $2.96 $0.95
Average True Range (ATR) 0.14 0.08
MACD -0.02 0.02
Stochastic Oscillator 23.73 70.49

Price Performance

Historical Comparison
INDO
TELA

About INDO Indonesia Energy Corporation Limited

Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

Share on Social Networks: